Table 2.

Top 6 research priorities identified by the Delphi process and their average scores

Research priority	Rank	Average
A better understanding of pancreatic cancer progression, metastases, and resistance to therapy	1	4.28
The establishment of a clinico-pathological database linked with standardised prospectively collected pancreatic cancer patient data	2	4.21
A better understanding of the early development and progression of pancreatic cancer and its precursor lesions to facilitate the development of novel early detection, screening, and chemoprevention strategies	3	4.20
The establishment of a pancreatic cancer tissue bank and strategies to encourage participation and support for this facility	4	4.17
Define biomarkers of prognosis and therapeutic responsiveness to facilitate the development of stratified and individualised therapy	5	4.12
Promoting the development of, and participation in, clinical trials of therapies and management for pancreatic cancer	6	4.04